The global infection control market size was valued at USD 55.3 billion in 2025 and is projected to grow from USD 59.06 billion in 2026 to USD 99.97 billion by 2034, registering a CAGR of 6.8% during the forecast period from 2026 to 2034. North America dominated the infection control market with a market share of 38.4% in 2025.
Infection control refers to the set of evidence-based practices, procedures, and preventive measures implemented to reduce the transmission of infectious microorganisms in healthcare and community settings. It includes hand hygiene, sterilization, disinfection, personal protective equipment (PPE), isolation protocols, environmental cleaning, and surveillance programs. Infection control plays a vital role in protecting patients, healthcare professionals, and the public by preventing healthcare-associated infections and improving overall safety.
Download a Free Sample To learn more about this report,
Growing Adoption of Advanced Disinfection and Infection Prevention Technologies
The infection control market is being driven by increasing awareness of healthcare-associated infections, rising surgical volumes, stricter hygiene requirements, and growing emphasis on patient and healthcare-worker safety. Hospitals, clinics, laboratories, pharmaceutical facilities, and other healthcare environments are increasingly adopting sterilization equipment, surface disinfectants, hand hygiene products, personal protective equipment, and automated disinfection technologies to reduce pathogen transmission. Advanced solutions such as UV-C disinfection, hydrogen peroxide systems, automated sterilizers, and high-level disinfectants are gaining attention because they can improve infection prevention while supporting efficient healthcare workflows. Manufacturers are also developing environmentally conscious formulations and products with shorter contact times to improve usability and reduce chemical exposure. In addition, digital traceability, automated monitoring, and connected infection-control systems are helping healthcare facilities improve compliance and document disinfection processes. These developments are strengthening infection prevention programs and supporting continued innovation across the healthcare infection control industry.
Rising Healthcare-Associated Infections and Increasing Focus on Patient Safety
Demand is supported by increasing awareness of healthcare-associated infections and the growing emphasis on preventing infection transmission across hospitals, clinics, ambulatory surgery centers, laboratories, pharmaceutical facilities, and other healthcare environments. Infection control products and services, including sterilization equipment, disinfectants, hand hygiene products, protective equipment, antimicrobial surfaces, and infection surveillance technologies, are essential for reducing the risk of cross-contamination and maintaining safe clinical environments. Growing surgical volumes, rising healthcare utilization, increasing prevalence of drug-resistant microorganisms, and stronger hospital-acquired infection prevention programs are encouraging healthcare facilities to strengthen infection prevention practices. Regulatory requirements, accreditation standards, and investments in hospital infrastructure are further supporting adoption of advanced infection control technologies.
High Costs of Advanced Sterilization Systems and Limited Resources in Developing Healthcare Facilities
The infection control market faces challenges due to the high acquisition, installation, maintenance, and operating costs associated with advanced sterilization equipment, automated disinfection systems, infection surveillance technologies, and specialized consumables. Healthcare facilities must also allocate resources for staff training, equipment validation, maintenance, and compliance with infection prevention protocols. Smaller hospitals and healthcare facilities in developing regions may have limited budgets, inadequate water and sanitation infrastructure, and restricted access to specialized sterilization technologies, which can slow adoption. Frequent replacement of certain single-use products can further increase operating expenses. These financial and infrastructure constraints can make it difficult for healthcare providers to implement comprehensive infection control programs despite the clinical importance of preventing healthcare-associated infections.
Expansion of Automated Disinfection, Sterilization, and Digital Infection Surveillance Technologies
The market is expected to benefit from increasing adoption of automated disinfection systems, advanced sterilization technologies, antimicrobial materials, rapid microbiological testing, and digital infection surveillance platforms. Automated ultraviolet-C disinfection, hydrogen peroxide vapor systems, and other no-touch technologies can complement conventional cleaning practices and help healthcare facilities improve environmental hygiene. Digital surveillance platforms can integrate laboratory, patient, antimicrobial use, and clinical data to identify infection trends and support earlier interventions. Growing demand for single-use medical products, advanced personal protective equipment, and antimicrobial surfaces is also creating additional opportunities for manufacturers. These developments are expected to strengthen the Infection Control Market by improving infection prevention efficiency, reducing human error, and enabling healthcare organizations to monitor risks more effectively.
Managing Antimicrobial Resistance, Compliance, and Consistent Infection Prevention Practices
Healthcare organizations must address challenges related to antimicrobial resistance, staff compliance, sterilization quality, environmental hygiene, and consistent implementation of infection prevention protocols. The emergence of resistant microorganisms can make infections more difficult to treat and increases the importance of rigorous hygiene, disinfection, sterilization, and surveillance practices. Healthcare facilities must ensure that staff follow established protocols for hand hygiene, equipment cleaning, instrument sterilization, isolation procedures, and appropriate use of protective equipment. Improper sterilization cycles, inadequate cleaning, incorrect disinfectant concentrations, or inconsistent compliance can undermine infection control programs. Facilities must also maintain detailed documentation and validation processes to demonstrate regulatory compliance, while advanced technologies require appropriate training and ongoing maintenance to deliver reliable performance.
The sterilization equipment segment dominated the infection control market with a market share of 58.7% and a value of USD 32.46 billion. It is projected to register a CAGR of 7.8% during the forecast period. Sterilization equipment maintains its leading position because effective sterilization is essential for eliminating microorganisms from medical instruments and preventing healthcare-associated infections. Hospitals and other healthcare facilities are increasingly investing in advanced sterilization technologies to meet stringent infection prevention requirements and improve patient safety. Growing surgical volumes, increasing awareness of infection control, and technological advancements in sterilization systems are further supporting demand for this segment.
Protective barriers play an important role in reducing the transmission of infectious agents between healthcare workers, patients, and contaminated environments. Products such as protective clothing, gloves, masks, and other barrier solutions are widely used across healthcare settings to strengthen infection prevention protocols. Increasing awareness of occupational safety, stricter hygiene standards, and the continued need for effective protection during medical procedures are supporting adoption of protective barriers.
Request Customizationto receive a tailored report.
The medical device sterilization segment dominated the infection control market with a market share of 46.2% and a value of USD 25.55 billion. It is projected to register a CAGR of 7.9% during the forecast period. Medical device sterilization maintains its leading position because reusable surgical instruments and medical devices require effective sterilization before use to minimize the risk of infection transmission. Rising surgical procedures, increasing use of reusable medical equipment, and stringent regulatory requirements for sterilization and reprocessing are supporting demand. Technological advancements in sterilization systems and growing emphasis on patient safety are further strengthening this application.
Pharmaceutical and biotechnology companies are increasingly adopting infection control solutions to maintain controlled manufacturing environments and protect pharmaceutical products from microbial contamination. The growing production of biologics, vaccines, sterile drugs, and other sensitive healthcare products is increasing the importance of contamination prevention throughout manufacturing and laboratory processes.
Other applications include healthcare, research, and specialized environments where maintaining hygienic and contamination-controlled conditions is essential. Growing awareness of infection prevention practices and the implementation of stricter sanitation protocols are supporting the broader use of infection control products across diverse applications.
The hospitals segment dominated the infection control market with a market share of 61.5% and a value of USD 34.01 billion. It is projected to register a CAGR of 7.4% during the forecast period. Hospitals maintain their leading position because they perform large numbers of surgeries, diagnostic procedures, and other treatments that require stringent infection prevention and sterilization protocols. High patient volumes and the need to protect patients and healthcare professionals from healthcare-associated infections are driving continuous investment in infection control equipment and protective solutions. Increasing regulatory focus on hospital hygiene, rising surgical activity, and growing awareness of patient safety are further supporting demand.
Ambulatory surgical centers are increasingly adopting infection control solutions as more surgical procedures shift from traditional hospitals toward outpatient settings. The growing number of minimally invasive and same-day procedures is increasing the need for reliable sterilization, disinfection, and protective measures within these facilities. Other end users are also strengthening infection prevention practices across healthcare and specialized environments as organizations place greater emphasis on reducing contamination risks and maintaining safe operating conditions.
Speak to an Analystto discuss market opportunities.
North America infection control market accounted for 38.4% of the global market, reaching USD 21.24 billion in 2025, and is projected to grow at a CAGR of 7.1% during the forecast period. The region maintains its leading position due to advanced healthcare infrastructure, strong adoption of sterilization and disinfection technologies, established infection prevention practices, and increasing focus on reducing healthcare-associated infections. Hospitals, clinics, laboratories, pharmaceutical facilities, and other healthcare environments are investing in sterilization equipment, disinfectants, protective products, cleaning solutions, and infection monitoring technologies. Growing awareness of antimicrobial resistance and the need for effective infection prevention are encouraging healthcare organizations to strengthen protocols. Automation, advanced sterilization systems, and improved monitoring technologies are further supporting regional market development.
The United States represents an important infection control market, supported by extensive healthcare infrastructure, established infection prevention programs, and strong demand for sterilization, disinfection, and protective technologies. Hospitals and healthcare facilities are increasingly investing in sterilization equipment, surface disinfectants, hand hygiene products, personal protective equipment, and infection surveillance solutions. Growing attention to healthcare-associated infections and antimicrobial resistance is encouraging organizations to strengthen infection prevention procedures. Pharmaceutical and medical device manufacturing facilities also require stringent contamination control and sterilization processes. Continued healthcare investment, technological innovation, and emphasis on patient safety are expected to support demand for advanced infection control solutions across the country.
Canada's infection control market is supported by established healthcare infrastructure, increasing emphasis on patient safety, and adoption of sterilization and disinfection technologies across hospitals and other healthcare facilities. Infection prevention programs are driving demand for disinfectants, sterilization equipment, hand hygiene solutions, protective products, and monitoring systems. Healthcare providers are increasingly focusing on reducing healthcare-associated infections and improving environmental hygiene. Laboratories, pharmaceutical facilities, and medical device manufacturers also require effective contamination control and sterilization processes. Continued investment in healthcare infrastructure and increasing awareness of infection prevention practices are expected to support market development across Canada.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific infection control market accounted for 22.5% of the global market, reaching USD 12.44 billion in 2025, and is projected to grow at the highest regional CAGR of 8.9% during the forecast period. Regional expansion is supported by increasing healthcare expenditure, development of hospitals and healthcare facilities, rising awareness of infection prevention, and growing adoption of advanced sterilization and disinfection technologies. Healthcare providers are strengthening infection control practices to improve patient safety and manage healthcare-associated infection risks. China and Japan represent important markets, while expanding healthcare infrastructure across emerging Asian economies is creating additional opportunities. Demand for sterilization equipment, disinfectants, protective products, antimicrobial technologies, and infection monitoring systems is expected to increase as healthcare capacity expands.
China's infection control market is supported by expanding healthcare infrastructure, increasing hospital capacity, rising awareness of infection prevention, and growing adoption of advanced sterilization technologies. Hospitals and healthcare facilities are strengthening hygiene and contamination control practices, creating demand for sterilizers, disinfectants, hand hygiene products, protective equipment, and infection monitoring solutions. Pharmaceutical and medical device manufacturing also requires stringent contamination control and sterilization procedures. Increasing healthcare expenditure and modernization of medical facilities are improving access to advanced infection prevention technologies. Continued development of healthcare infrastructure and growing emphasis on patient safety are expected to support market expansion across China.
Japan's infection control market is supported by advanced healthcare infrastructure, established infection prevention practices, strong medical technology capabilities, and increasing demand for effective sterilization and disinfection solutions. Hospitals, laboratories, pharmaceutical facilities, and medical device manufacturers use advanced contamination control technologies to maintain safety and quality standards. Demand is supported by an aging population and the need to maintain high standards of healthcare hygiene. Manufacturers are developing efficient sterilization equipment, antimicrobial solutions, monitoring technologies, and automated systems to improve infection prevention. Continued healthcare modernization and technological innovation are expected to support market development in Japan.
Middle East and Africa infection control market accounted for 5.1% of the global market, reaching USD 2.82 billion in 2025, and is projected to grow at a CAGR of 7% during the forecast period. Regional growth is supported by healthcare infrastructure development, expansion of hospitals and clinics, increasing awareness of infection prevention, and rising investment in modern medical technologies. Healthcare facilities are increasingly adopting sterilization equipment, disinfectants, hand hygiene solutions, protective products, and infection monitoring systems. Expansion of private healthcare networks and specialized medical facilities is creating additional demand for contamination control technologies. Continued investment in healthcare quality and patient safety is expected to support infection control market development across major regional economies.
The UAE represents an emerging infection control market supported by advanced healthcare infrastructure, expansion of private healthcare facilities, and increasing adoption of modern sterilization and disinfection technologies. Hospitals, clinics, laboratories, and other healthcare organizations are investing in infection prevention products and systems to maintain high standards of hygiene and patient safety. Demand includes sterilization equipment, surface disinfectants, hand hygiene products, protective solutions, and monitoring technologies. The development of specialized healthcare facilities and medical tourism is further increasing the importance of effective infection prevention practices. Continued healthcare modernization and investment in advanced medical technologies are expected to support market growth in the UAE.
Saudi Arabia's infection control market is supported by healthcare infrastructure expansion, modernization of hospitals, increasing healthcare investment, and growing emphasis on patient safety and infection prevention. Healthcare facilities are increasingly adopting sterilization equipment, disinfectants, hand hygiene solutions, protective products, and infection monitoring technologies. Development of specialized hospitals and private healthcare networks is creating additional opportunities for advanced infection control solutions. Pharmaceutical and medical device manufacturing activities also require effective contamination control and sterilization processes. Continued healthcare modernization and investment in quality-focused medical infrastructure are expected to support market development across Saudi Arabia.
Europe infection control market accounted for 27.6% of the global market, reaching USD 15.26 billion in 2025, and is projected to grow at a CAGR of 6.8% during the forecast period. The region benefits from established healthcare systems, mature infection prevention practices, advanced sterilization infrastructure, and strong focus on patient safety. Hospitals, laboratories, pharmaceutical manufacturers, and medical device companies use a broad range of infection control technologies, including sterilization equipment, disinfectants, antimicrobial products, protective solutions, and monitoring systems. Growing concerns surrounding antimicrobial resistance and healthcare-associated infections are encouraging continued investment in effective prevention measures. Automation, improved sterilization processes, and technology-enabled monitoring are further supporting market development.
Germany's infection control market is supported by advanced healthcare infrastructure, established hygiene practices, strong medical technology capabilities, and extensive hospital and laboratory networks. Healthcare organizations increasingly invest in sterilization equipment, disinfectants, infection monitoring systems, and protective products to maintain effective contamination control. Pharmaceutical and medical device manufacturing facilities also require reliable sterilization and clean-environment technologies. Increasing attention to healthcare-associated infections and antimicrobial resistance is encouraging continuous improvement of infection prevention procedures. Adoption of automated sterilization and monitoring technologies is further improving operational efficiency, supporting sustained market demand across Germany.
The United Kingdom has a well-established infection control market supported by advanced healthcare infrastructure, strong infection prevention practices, and continued focus on reducing healthcare-associated infections. Hospitals, clinics, laboratories, and other healthcare facilities use sterilization equipment, disinfectants, hand hygiene products, protective solutions, and infection monitoring technologies. Healthcare providers are increasingly emphasizing effective cleaning, sterilization, environmental hygiene, and infection surveillance. Pharmaceutical and medical device facilities also require stringent contamination control procedures. Continued investment in healthcare quality, patient safety, and advanced infection prevention technologies is expected to support market development across the UK.
The global infection control market includes major healthcare technology companies, sterilization equipment manufacturers, infection prevention specialists, and medical consumables providers competing through product innovation, sterilization efficiency, infection prevention technologies, and comprehensive healthcare solutions. 3M Company, Ecolab Inc., Belimed AG, Getinge AB, Matachana Group, MMM Group, Sotera Health Inc., STERIS PLC, ASP, and O&M Halyard compete across sterilization systems, disinfectants, infection prevention products, surgical supplies, and healthcare facility solutions. Competition is shifting toward advanced sterilization technologies, automated disinfection systems, environmentally sustainable solutions, antimicrobial products, and improved monitoring technologies to address healthcare-associated infections. Companies are also investing in low-temperature sterilization, hydrogen peroxide-based technologies, digital monitoring, automated reprocessing systems, and innovative infection prevention products while expanding partnerships with hospitals and healthcare facilities to improve sterilization efficiency, patient safety, regulatory compliance, and overall infection control outcomes.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Ambulance Services Market Size, Share, Growth, Analysis, 2034
North America Clinical Trial Imaging Market Size, Share, and Forecast 2034
Europe Clinical Trial Imaging Market Analysis, Trends, Forecast Up to 2034
Asia Pacific Clinical Trial Imaging Market Size, Share and Forecast to 2034
India Pharmaceutical Stability and Storage Services Market Size, Share & Trends | Industry Report, 2034
Healthcare Regulatory Affairs Outsourcing Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com